Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Supplementary Issue 2

COVID-19 has been a global challenge caused by a coronavirus that infects the respiratory system and poses a high risk to life. This study dealt with some immunological indicators associated with this disease Continue reading

Τόμος 34 (2020) – Τεύχος 3 –Άρθρο 5 – Review of Clinical Pharmacology and Pharmacokinetics – Διεθνής Έκδοση – Volume 34 (2020) – Issue 3 – Article 5 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

The current transmission of Coronavirus Disease (COVID-19) has raised multiple concerns across all over the world. Until now, no effective treatment has been established for COVID-19 and this virus may also affect young people or people who do not belong to a vulnerable group. Continue reading

Volume 37 (2023) – Issue 2 – Article 4 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Cardiovascular diseases (CVDs) remain a significant global health concern, contributing to substantial morbidity and mortality.
Continue reading

Volume 37 (2023) – Issue 2 – Article 2– Review of Clinical Pharmacology and Pharmacokinetics – International Edition

The global COVID-19 pandemic has posed significant challenges to healthcare systems worldwide. Vulnerable populations, such as individuals with underlying health conditions, are particularly at risk. Continue reading

Volume 37 (2023) – Issue 2 – Article 5 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

The incidence of emerging infectious diseases has increased during the past two decades and is expected to further increase. Continue reading